LifeSciencePLUS, Inc., is pleased to announce the recertification of its Class IIb CE Mark Certification for the BloodSTOP® line of topical hemostats. The recertification has been extended to include bleeding control for people on anti-coagulant medications.
Recent Posts
- LSU Health Study Finds BloodSTOP® iX Trauma Matrix Improves Hemorrhage Control and Survival, Presented at MHSRS 2026
- LifeScience PLUS Secures FDA 510(k) Clearance for BloodSTOP® iX Trauma Matrix for Severe Bleeding Control
- Potential New Application for BloodSTOP® iX in Neurosurgical CSF Leakage Management
- Jacobi Burn Center Highlights Clinical Success with BloodSTOP iX at ABA Annual Meeting
- LifeScience PLUS Announces Publication on Revolutionary eCMC Technology in The Journal of Burn Care and Research